HYPR trades 193.6% below Wall Street's consensus target of $1.60.
Last 12 months price action with 12-month analyst target path
The base valuation assumes HYPR achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 4 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 19, 2026, Hyperfine, Inc. (HYPR) has a Wall Street consensus price target of $1.60, based on estimates from 4 covering analysts. With the stock currently trading at $0.54, this represents a potential upside of +193.6%. The company has a market capitalization of $46M.
Analyst price targets range from a low of $1.60 to a high of $1.60, representing a 0% spread in expectations. The median target of $1.60 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 3 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, HYPR trades at a trailing P/E of -1.9x. Analysts expect EPS to grow -23.4% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
PRCTPROCEPT BioRobotics Corporation | $1.4B | $25.18 | $23.00 | -8.7% | Buy | — | 17 |
NVCRNovocure Ltd | $1.2B | $10.73 | $26.00 | +142.3% | Buy | — | 15 |
INVAInnoviva, Inc. | $1.4B | $18.40 | $38.00 | +106.5% | Buy | 7.6x | 11 |
AEYEAudioEye, Inc. | $137M | $11.00 | $21.00 | +90.9% | Buy | 10.6x | 7 |
GEHCGE HealthCare Technologies Inc. | $37.8B | $83.66 | $81.14 | -3.0% | Buy | 16.7x | 20 |
SYKStryker Corporation | $122.0B | $318.15 | $354.47 | +11.4% | Buy | 21.4x | 52 |
IRTCiRhythm Technologies, Inc. | $3.1B | $94.87 | $169.63 | +78.8% | Buy | — | 22 |
INSPInspire Medical Systems, Inc. | $1.7B | $58.11 | $64.67 | +11.3% | Hold | 46.6x | 29 |
NVDANVIDIA Corporation | $3.7T | $150.96 | $339.17 | +124.7% | Buy | 16.2x | 79 |
MSFTMicrosoft Corporation | $3.8T | $508.29 | $611.74 | +20.4% | Buy | 25.4x | 83 |
Quick answers to the most common questions about buying HYPR stock.
The consensus Wall Street price target for HYPR is $1.6, representing 193.6% upside from the current price of $0.5449. With 4 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
HYPR has a consensus rating of "Buy" based on 4 Wall Street analysts. The rating breakdown is predominantly bullish, with 3 Buy/Strong Buy ratings. The consensus 12-month price target of $1.6 implies 193.6% upside from current levels.
HYPR's current price is $0.5449 with a consensus target of $1.6 (193.6% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $1.6 for HYPR, while the most conservative target is $1.6. The consensus of $1.6 represents the median expectation. These targets typically reflect 12-month expectations.
HYPR is lightly followed, with 4 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month HYPR stock forecast based on 4 Wall Street analysts shows a consensus price target of $1.6, with estimates ranging from $1.6 (bear case) to $1.6 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on HYPR, with a "Buy" consensus rating and $1.6 price target (193.6% upside). 3 of 4 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
HYPR analyst price targets range from $1.6 to $1.6, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $1.6 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.